Mayo Clinic partnered with South Korea-based AI company Vuno to develop AI and machine learning for more precise diagnosis, prognosis and treatment stratification in cancer, according to an April 25 press release.
The collaborative agreement will combine Mayo Clinic’s AI research, clinical expertise and resources with Vuno’s AI research and development capabilities to create a broad spectrum of predictive and prognostic biomarkers.
The biomarkers aim to help make therapeutic decisions, which will improve the quality of cancer patient care.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.